Log In
BCIQ
Print this Print this
 

SR-Risperidone (PT801)

  Manage Alerts
Collapse Summary General Information
Company Peptron Inc.
DescriptionBiweekly injectable formulation of risperidone
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT) receptor
Mechanism of ActionDopamine D2 receptor antagonist; Serotonin (5-HT) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBipolar disorder
Indication DetailsTreat schizophrenia-associated bipolar disorder
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today